期刊文献+

HPV16/18型病毒检测在宫颈癌筛查中的价值 被引量:2

Value of HPV 16/18 detection in cervical cancer screening
原文传递
导出
摘要 目的探讨HPV16/18型病毒检测与宫颈癌的相关性。方法选取宝鸡市中心医院2011-2014年收治的宫颈鳞癌患者100例作为宫颈癌组,并选取同期在该院体检中心接受体检的健康受试者100例作为对照组,分别取两组受试者的宫颈分泌物,提取DNA,通过q PCR技术对HPV16/18 DNA的载量进行测定,比较两组受试者的检测阳性率。结果宫颈癌患者和健康受试者的HPV16/18 DNA载量相对值分别为(7.77±4.05)和(4.50±3.05),阳性率分别为77.00%和27.00%,宫颈癌患者显著高于健康受试者,经比较差异有统计学意义(P<0.05)。结论宫颈鳞癌与HPV16/18型病毒感染之间存在显著相关性,通过早发现、早期疗,做好对高危人群的筛查是宫颈癌防治的重要方法。 Objective To explore the correlation between HPV16/18 detection and cervical cancer. Methods A total of 100 patients with cervical cancer were selected as cervical cancer group from the hospital from 2011 to 2014,and 100 healthy subjects receiving physical examination in physical examination center of the hospital were selected as control group. The cervical secretion samples and DNA in the two groups were extracted respectively. HPV16/18 DNA load was measured by q PCR technique,and positive rates in the two groups were compared. Results The relative values of HPV16/18 DNA load in cervical cancer patients and healthy subjects were( 7. 77 ± 4. 05) and( 4. 50±3. 05),respectively,and the positive rates were 77. 07% and 27. 27%,respectively. The relative value of HPV16/18 DNA load and positive rate in patients with cervical cancer were statistically significantly higher than those in healthy subjects( P 0. 05).Conclusion There is a significant correlation between cervical squamous cell carcinoma and HPV 16/18 infection. It is an important method to prevent and treat cervical cancer through early detection,early treatment and good screening for high-risk population.
出处 《中国妇幼保健》 CAS 2017年第16期3725-3727,共3页 Maternal and Child Health Care of China
基金 宝鸡市卫生和计划生育局科研课题(2015-02)
关键词 HPV16/18型病毒 宫颈鳞癌 DNA HPV 16/18 Cervical squamous cell carcinoma DNA
  • 相关文献

参考文献8

二级参考文献96

  • 1鲍彦平,李霓,王鹤,乔友林.中国妇女子宫颈人乳头瘤病毒型别分布的Meta分析[J].中华流行病学杂志,2007,28(10):941-946. 被引量:79
  • 2Qi Zeng,Shiwen Peng,Archana Monie,et al.Control of cervicovaginal HPV-16 E7-Expressing tumors by the combination of therapeutic HPV vaccination and vascular disrupting Agents[J].Human Gene Therapy,2011;22(7):809-19.
  • 3Narisawa-Saito M,Kiyono T.Basic mechanisms of high-risk human papil-lomavirus-induced carcinogensis:roles of E6 and E7 proteins[J].Cancer Science,2007;98(10):1505-11.
  • 4Wang SM,Shi JF,Kang DJ,et al.Impact of human papillomavirus-related lesions on quality of life:a multicenter hospital-based study of women in China's Mainland[J].Int J Gynecol Cancer,2011;21(1):182-8.
  • 5Trimble CL,Frazer IH.Development of therapeutic HPV vaccines[J].Lancet Oncol,2009;10(10):975-80.
  • 6Moscicki AB.HPV vaccines:Today and in the future[J].Adolesc Health,2008;43(4):26-40.
  • 7Yugawa T,Kiyono T.Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses:novel functions of E6 and E7 oncopro-teins[J].Med Virol,2009;19(2):97-113.
  • 8Lin K,Doolan K,Hung CF,et al.Perspectives for preventive and thera-peutic HPV vaccines[J].Formos Med Assoc,2010;109(1):4-24.
  • 9Hung CF,Ma B,Monie A,et al.Therapeutic human papillomavirus vac-cines:current clinical trials and future directions[J].Expert Opin Biol T-her,2008;8(4):421-39.
  • 10Cubillos-Zapata C,Guzman E,Turner A,et al.Differential effects of viral vectors on migratory afferent lymph dendritic cells in vitro predict en-hanced immunogenicity in vivo[J].J Virol,2011;85(18):9385-94.

共引文献56

同被引文献25

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部